
Large study finds Pfizer mRNA vaccine lowers myocarditis risk in teens and young adults vs infection
A large retrospective study of about 4.1 million people aged 16–25 found that Pfizer/BNT162b2 vaccination is associated with lower risk of myocarditis, pericarditis, and death than SARS-CoV-2 infection; infection carries a higher cardiac risk than vaccination, though vaccine-associated myocarditis remains rare.












